Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion ...Middle East

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation from EMA's CHMP committee is based on a robust analytical, non-clinical and clinical data package comparing the biosimilar...

Hence then, the article about golimumab biosimilar gotenfia from stada and bio thera receives positive chmp opinion was published today ( Friday 12/12/2025 - 01:35 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion )

Also on site :

• Hollywood mourns loss of beloved makeup artist Jasen Kaplan
• Rose Parade 2026 awards announced: Top honor goes to Cal Poly Universities
• Kristi Noem, Stephen Miller Dance to & 039;Ice Ice Baby& 039; at New Year& 039;s Eve Party